financetom
Business
financetom
/
Business
/
Trump Media slips in choppy trading after Donald Trump's criminal conviction
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump Media slips in choppy trading after Donald Trump's criminal conviction
May 31, 2024 7:46 AM

(Reuters) -Shares of Trump Media & Technology Group fell 8% in choppy trading on Friday, after a jury found former U.S. president Donald Trump guilty of falsifying documents to cover up a payment to silence a porn star ahead of the 2016 election.

The stock opened higher and was among the top trends on Reddit's discussion forum WallStreetBets, indicating strong interest from individual traders. A majority of the firm's 621,000 shareholders are retail investors, as of April 29, the company has said.

"It's a meme stock that has no fundamentals. The volatility today is not surprising," said Art Hogan, chief market strategist at B. Riley Wealth.

The Republican presidential candidate for this year's election owns a majority stake in TMTG, the parent of his social media platform Truth Social. The company also provides a way for Trump supporters to bet on his resurgence as a political figure.

The 12-member New York jury pronounced Trump guilty on all the 34 felony counts he faced, making him the first U.S. president to be convicted of a crime.

The broader market showed little impact after the verdict in the case that was widely regarded as the least consequential of the four criminal prosecutions Trump faces. Neither a criminal conviction nor a prison sentence will affect Trump's eligibility to become president if he wins the Nov. 5 election.

Trump's net worth is tied to his stake in TMTG. He owned 64.9% of the company as of April 26, which is worth $5.7 billion.

TMTG's current valuation of approximately $9.2 billion is equivalent to about 2,200 times the loss-making company's $4.1 million revenue in 2023, according to LSEG data.

"The valuation of that stock has always been a bit of a question mark. It certainly isn't making any money and is trading almost at an unfathomable level," Hogan said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Taylor Morrison Home Insider Sold Shares Worth $2,714,211, According to a Recent SEC Filing
Taylor Morrison Home Insider Sold Shares Worth $2,714,211, According to a Recent SEC Filing
Mar 8, 2024
08:52 AM EST, 03/08/2024 (MT Newswires) -- William H Lyon, Director, on March 07, 2024, sold 46,668 shares in Taylor Morrison Home ( TMHC ) for $2,714,211. Following the Form 4 filing with the SEC, Lyon has control over a total of 2,652,630 shares of the company, with 17,744 shares held directly and 2,634,886 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1562476/000095014224000651/xslF345X03/es240456131_4-lyon.xml...
Liberty Broadband Insider Sold Shares Worth $1,141,885, According to a Recent SEC Filing
Liberty Broadband Insider Sold Shares Worth $1,141,885, According to a Recent SEC Filing
Mar 8, 2024
08:48 AM EST, 03/08/2024 (MT Newswires) -- David J Wargo, Director, around March 05, 2024, sold 20,000 shares in Liberty Broadband ( LBRDA ) for $1,141,885. Following the Form 4 filing with the SEC, Wargo has control over a total of 100,486 shares of the company, with 97,332 shares held directly and 3,154 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1611983/000122520824003874/xslF345X03/doc4.xml Price: 57.52,...
Eli Lilly's Phase 3 Trial Faces Advisory Committee Meeting by US FDA to Discuss Donanemab's Safety, Efficacy
Eli Lilly's Phase 3 Trial Faces Advisory Committee Meeting by US FDA to Discuss Donanemab's Safety, Efficacy
Mar 8, 2024
08:52 AM EST, 03/08/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Friday that the US Food and Drug Administration will call an advisory committee meeting to discuss the phase 3 Trailblazer-Alz 2 trial of donanemab in early Alzheimer's disease. The regulator needs additional understanding of topics regarding the safety and efficacy of donanemab, the company added. Eli Lilly...
Skyharbour Resources Partner Company North Shore Uranium Begins Drill Program at Falcon Uranium Property
Skyharbour Resources Partner Company North Shore Uranium Begins Drill Program at Falcon Uranium Property
Mar 8, 2024
08:54 AM EST, 03/08/2024 (MT Newswires) -- Skyharbour Resources Ltd. ( SYHBF ) announced that its partner company, North Shore Uranium (NSU.V), has begun its drill program at the Falcon Property, located at the eastern margin of the Athabasca Basin in northern Saskatchewan. North Shore is planning to drill three targets associated with electromagnetic (EM) conductors. The drill program is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved